Novartis Stock Borsa Italiana
Stocks
NOVN
CH0012005267
Pharmaceuticals
OTC Markets Traded| Market Cap | 292B 253B 237B 217B 410B 27,798B 417B 2,790B 1,093B 13,863B 1,095B 1,071B 45,723B | P/E 2026 * |
21.8x | P/E 2027 * | 18.6x |
|---|---|---|---|---|---|
| Enterprise Value | 325B 282B 264B 242B 456B 30,955B 464B 3,107B 1,217B 15,437B 1,220B 1,193B 50,915B | EV / Sales 2026 * |
5.64x | EV / Sales 2027 * | 5.23x |
| Free-Float |
91.66% | Yield 2026 * |
2.85% | Yield 2027 * | 2.97% |
Last Transcript: Novartis
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2018-01-31 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 2026-03-15 |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 64 | 2022-05-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 2014-12-31 |
| Director/Board Member | 69 | 2015-12-31 | |
Ton Büchner
BRD | Director/Board Member | 61 | 2015-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -2.58% | - | - | 292B | |
| -2.39% | -6.36% | +47.10% | +149.66% | 1T | |
| -0.76% | -4.34% | +52.04% | +49.09% | 613B | |
| -2.33% | -4.60% | +25.55% | +64.44% | 433B | |
| +0.68% | -1.14% | +38.47% | +33.36% | 350B | |
| -8.96% | -10.77% | +3.57% | +5.50% | 239B | |
| -1.37% | -7.41% | -2.10% | -43.67% | 206B | |
| -1.63% | +0.69% | +27.62% | +64.23% | 204B | |
| +0.72% | +0.48% | +15.88% | +73.64% | 163B | |
| +0.08% | +1.46% | +6.56% | -28.49% | 143B | |
| Average | -1.01% | -2.90% | +23.85% | +40.86% | 372.39B | |
| Weighted average by Cap. | -0.68% | -3.92% | +33.75% | +69.44% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.58B 50.05B 46.72B 42.89B 80.88B 5,489B 82.29B 551B 216B 2,737B 216B 212B 9,028B | 61.12B 53.12B 49.6B 45.53B 85.85B 5,826B 87.35B 585B 229B 2,905B 230B 225B 9,583B |
| Net income | 13.78B 11.98B 11.18B 10.26B 19.35B 1,313B 19.69B 132B 51.64B 655B 51.76B 50.62B 2,160B | 15.36B 13.35B 12.46B 11.44B 21.57B 1,464B 21.95B 147B 57.55B 730B 57.69B 56.41B 2,408B |
| Net Debt | 33.11B 28.78B 26.87B 24.67B 46.51B 3,156B 47.32B 317B 124B 1,574B 124B 122B 5,192B | 27.82B 24.18B 22.57B 20.72B 39.07B 2,651B 39.75B 266B 104B 1,322B 104B 102B 4,361B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
